Treatment

For years, a 4.5-hour window was considered a major limit for administering clot-dissolving drugs after an ischemic stroke. A study reviewing 14 trials and over 4,000 patients shows that in carefully selected patients, mainly with the help of advanced imaging, treatment may be beneficial even at a later stage. Dr. Roni Eichel, a stroke expert at Shaare Zedek: "The approach must be fast, because...

Just before the start of the school year, as more parents are re-examining treatment options for Attention Deficit Hyperactivity Disorder (ADHD), a new drug has been approved in the United States that is generating significant interest in the medical community. It is Simtriyo (centanafadine), which was recently approved by the U.S. Food and Drug Administration (FDA) for the treatment of children...